TSLP and breast carcinoma: Interestingly, TSLP levels in terminal PyMttg TslprKO tumors were restored back to WT mammary gland levels, suggesting that TSLP loss in breast cancer is due to negative selection against this cytokine to escape TSLP-induced Th2 cell immunity during the early malignant transformation (Fig. 8 E).